TheEdgeResearch
Home / Stocks / UMAX

UMAX Group Corp (UMAX)

OTC Technology Software - Application
$0.00 ▲ +0.00%
Market Cap
$236
Sector
Technology
Industry
Software - Application
Beta
-0.10
52-Wk Range
0.0001-0.0002
CEO
Gerald Edick
Country
US
Currency
USD

UMAX Group Corp operates in the Software - Application industry of the Technology sector, headquartered in Los Angeles, CA, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $236. On trailing twelve-month figures it carries a trailing P/E of -0.14, a net margin of -848.0%. Its beta of -0.10 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-0.14
Price / Sales
0.01
Price / Book
-0.04
EV / EBITDA
-7.02
Gross margin
-118.8%
Operating margin
-819.9%
Net margin
-848.0%
Return on equity
Debt / equity
-1.68
Current ratio
0.00
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
0
IPO date
2013-02-20
Headquarters
Los Angeles, CA, US
About UMAX Group Corp

UMAX Group Corp., a development stage company, doing business as UMAX Nutrition, focuses on developing and distributing natural and organic nutrition, and dietary supplements to the nutritional industry. Its product line provides dietary needs for weight loss, colon health, sexual health, body building, and general health and vitality. The company’s products include UPRITE XXL, a natural herbal male enhancement supplement providing an alternative to prescription erectile dysfunction medication; green coffee bean extract; and RASPBERRY KETONE, an anti-oxidant and fat burning ingredient. UMAX Group Corp. was founded in 2011 and is based in Los Angeles, California.

Comparable companies

UMAX Group Corp is most often compared with the following Technology names:

AHFDEZTDITUPMERRNVPLFQIANSFINSMFXSPOIWSFGQ
More research on UMAX
UMAX technical analysis UMAX TheEdge Score Compare against peers
Open full interactive analysis & DCF →